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Background: Delaying HIV care initiation may lead to greater
morbidity, mortality, and further HIV transmission. Rural residence
may be associated with delayed diagnosis and linkage to care, with
negative clinical outcomes.
Objective: To examine the association between rural patient
residence and CD4 cell count at HIV care initiation in a large HIV
clinical cohort in the Southeastern United States.
Methods: We included HIV-infected patients who initiated care
between 1996 and 2012 with a geocodable address and no previous
history of HIV clinical care. Patient residence was categorized as
urban or rural using United States Department of Agriculture Rural
Urban Commuting Area codes. Multivariable linear regression
models were fit to estimate the association between patient residence
and CD4 cell count at HIV care initiation.
Results: Among 1396 patients who met study inclusion criteria,
988 had a geocodable address. Overall, 35% of patients resided in
rural areas and presented to HIV care with a mean CD4 cell count of
351 cells/mm3 (SD, 290). Care initiation mean CD4 cell counts
increased from 329 cells/mm3 (SD, 283) in 1996–2003 to 391 cells/
mm3 (SD, 292) in 2008–2012 (P = 0.006). Rural in comparison with
urban patients presented with lower CD4 cell counts with an
unadjusted and adjusted mean difference of 248 cells/mm3 [95%
confidence interval, 286 to 210) and 237 cells/mm3 (95%
confidence interval: 273 to 22), respectively, consistently observed
across calendar years.
Conclusions: HIV care initiation at low CD4 cell counts was
common in this Southeastern US cohort and more common among
rural area residents.
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INTRODUCTION
HIV infection is a chronic, manageable condition
for most individuals who access HIV care and initiate
antiretroviral therapy (ART) early and consistently after
infection.1–3 However, delays in HIV care initiation are
associated with poor prognosis including less than optimal
ART outcomes and greater risk of morbidity and mortality.4,5
Late care entry is also associated with greater medical care
costs and prolonged risk period for HIV transmission.6–8
In the United States, an estimated 1 in 8 people infected
with HIV are unaware of their infection.9 Furthermore,
a quarter of HIV-infected persons are diagnosed with clinical
and/or immunologic AIDS within 3 months, and a third
within a year, of HIV diagnosis.10 The median CD4 cell count
at the first presentation for care has increased in recent years,
but remains below 350 cells/mm3 for more than half of U.S.
patients.11,12 A number of patient characteristics may be
associated with delays in HIV care initiation, including sex,
age, race/ethnicity, and health insurance.11,13
Structural and social characteristics may also affect
patient care engagement. Rural residence may specifically
negatively affect HIV care receipt and clinical outcomes14–16
as well as retention.14,17 HIV-infected persons living outside
urban centers may have less access to HIV experts and
facilities, incur greater costs and time traveling for care, face
greater stigma, have more concerns about privacy and
anonymity, and have fewer or no ancillary care services.18,19
With increasing emphasis on addressing gaps in the
HIV cascade and continuum,20 we undertook this study to
specifically assess the effect of rural residence on HIV care
entry. Relying on a large HIV clinical cohort study in the
Southeastern United States, we evaluated differences in
patient characteristics at care entry by rural residence and
examined whether living in a rural area affected timing of
HIV care initiation.
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METHODS
Study Design and Population
This study used UNC CFAR HIV Clinical Cohort 
(UCHCC) data which include HIV-infected patients receiving 
primary HIV care from 1996 to the present at a large tertiary care 
facility in the Southeastern United States. UCHCC data include 
information from electronic health and administrative institu-
tional records, periodic medical chart reviews, and links to 
external sources including mortality data. The UCHCC and its 
procedures have been previously described.21 Patients aged at 
least 18 years who initiated HIV care between 1996 and 2012 
were eligible for this study. We excluded patients who initiated 
HIV care at a different institution. Patients provided written 
informed consent to participate in the UCHCC, and the UCHCC 
as well as this study were approved by the Institutional Review 
Board at the University of North Carolina at Chapel Hill.
Measures
Our primary outcome of interest was the patient’s CD4  
cell count at first presentation to HIV clinical care, defined as 
first available CD4 cell count available within 60 days of the first 
HIV clinical care visit among patients with no previous HIV 
care. We considered a continuous CD4 measure as well as 
categories representing varying degrees of immunosuppression. 
Our primary exposure of interest was rural residence, which was 
defined according to the U.S. Department of Agriculture 
(USDA)’s Rural-Urban Commuting Area Codes (RUCAs), 
a robust 2000 census-tract classification based on urbanized 
area/cluster definitions of core population size and work 
commuting data. We used Arc-GIS to geocode the patient’s 
first reported home address and assign RUCA codes. We first 
assigned residence based on 4 RUCA codes (urban, large rural, 
small rural, and isolated small rural); however, given the limited 
sample sizes in small and isolated small rural areas, we chose to 
use a common algorithm (USDA’s Categorization C, version 2) 
that dichotomizes residence as rural or urban.22
We considered a number of patient demographic and 
clinical characteristics as possible effect measure modifiers 
and confounders of the relationship between residence and 
CD4 cell count at HIV care initiation, including sex, age, 
race/ethnicity, being a man who has sex with men, history of 
intravenous drug use, log10 HIV RNA level, Hepatitis C 
coinfection (HCV), health insurance, driving distance to the 
clinic and calendar year. These factors were chosen based on 
a directed acyclic graph we created for this project, and based 
on evidence that these factors may be different between rural 
and urban residents, and may affect timing of HIV care 
initiation.11,19 Patients of reported Hispanic ethnicity were 
included as “other” race/ethnicity and not as white or black. 
Patients were classified as having an AIDS-defining clinical 
condition if diagnosed with a CDC category C condition 
within 180 days of first clinical care entry.23
Statistical Analyses
We compared rural and urban patient characteristics 
using standard statistical approaches including t test, x2 test,
and the Wilcoxon or Kruskal–Wallis tests. We reported 
unadjusted and adjusted mean values for CD4 cell count. The 
association between patient residence (urban or rural) and 
continuous CD4 cell count was examined using multiple 
linear regression. Multivariable analyses were fit to adjust for 
confounding by demographic and clinical factors measured at 
first presentation to HIV care. The change-in-estimate 
criterion was used to assess confounding after first testing 
for effect measure modification using an alpha of 0.10. As 
indicated, we considered alternate parameterization of con-
tinuous characteristics including fitting flexible splines to 
improve model fit and estimation.
In sensitivity analyses, having a CD4 cell count 
,200 cells/mm3 or ,350 at HIV care entry was compared 
between urban and rural patients using multivariable log-
linear regression. Because HIV testing guidelines have 
changed over the course of this study, we also performed 
our primary analyses among patients who initiated HIV care 
in more recent calendar years, specifically 2001 to 2012. 
Furthermore, we performed our primary analyses using 
multiple imputation including patients who we were not able 
to geocode. For the multiple imputation, we used a multivar-
iate normal model to impute missing rural residence 50 times 
and used Rubin’s rule to combine imputations.24 Variables 
included in the imputation model were the same as variables 
used in the primary analysis. Hypothesis testing was 2-sided 
with an alpha level of 0.05. Data were analyzed using SAS 
version 9.3 (SAS Institute, Cary, NC).
RESULTS
Between 1996 and 2012, 1396 UCHCC patients 
initiated HIV care and met our inclusion criteria. In the 
primary analysis, we excluded 408 patients (29%) without 
a geocodable address (eg, only PO Box provided or address 
unavailable). These excluded patients were similar to those 
with geocoded addresses (data not shown). The final study 
population of patients with geocodable addresses of residence 
included 988 patients, of whom 69% were men. The mean 
age at care entry was 37 years (SD, 11), and 60% were black, 
26% white, and 14% of other race or ethnicity, most of whom 
were Hispanic (60%) (Table 1). At HIV care initiation, the 
mean CD4 cell count was 351 cells/mm3 (SD, 290), with 
18%, 19%, 18%, 18%, and 27% having CD4 cell counts ,50, 
50–199, 200–349, 350–499, and $500 cells/mm3, respec-
tively. The mean log10 HIV RNA level was 4.5 (SD, 0.98), 
and 20% were diagnosed with an AIDS-defining clinical 
condition. The mean year of HIV care initiation was 2003 
(SD, 4.8). We noted a modest increase in mean CD4 cell 
count at care initiation over calendar time, with a CD4 cell 
count of 329 cells/mm3 (SD, 283) for 1996–2003 versus 391 
cells/mm3 (SD, 292) for 2008–2012 (P = 0.006).
Patients resided in urban (65%), large rural (25%), 
small rural (8%), and isolated small rural areas (1%), and for 
this study, we combined the 3 rural categories. There were 
342 patients (35%) who lived in a rural area. Rural in 
comparison with urban patients were older (mean, 38 versus 
36 years) and started care in earlier calendar years (mean, 
2002 versus 2003), (P = 0.0001 and P = 0.0005, respectively)
immunosuppression in multivariable analyses included male
sex, older age, non-white race (with both black and primarily
Hispanic other race/ethnicity patients presenting with lower
CD4 cell counts than whites), not being a man who has sex
with men, and higher HIV RNA level. Neither distance to
care, type of health insurance, nor HCV co-infection was
associated with CD4 cell count at HIV care entry. In adjusted
analyses, rural patients presented with lower CD4 cell counts
TABLE 1. Patient Characteristics at HIV Care Initiation,








(N = 646) P
Male sex, no. (%) 686 (69) 234 (68) 452 (70) 0.6
Age, yr 0.0001
Mean (SD) 37 (11.0) 38 (11.3) 36 (10.7)
Race,† no. (%) 0.009
White 256 (26) 84 (25) 172 (27)
Black 593 (60) 194 (57) 399 (62)
Other 139 (14) 64 (19) 75 (12)
MSM, no. (%) 397 (40) 118 (35) 279 (43) 0.008




Mean (SD) 351 (290) 320 (279) 368 (295)
HIV RNA level, log10
copies/mL
0.8
Mean (SD) 4.54 (0.98) 4.55 (0.98) 4.54 (0.99)
AIDS clinical
condition, no. (%)
194 (20) 77 (23) 117 (18) 0.1
HCV, no. (%) 151 (15) 67 (20) 84 (13) 0.006
Insurance, no. (%) 0.002
None 487 (49) 162 (47) 325 (50)
Private 248 (25) 71 (21) 177 (28)
Public 253 (26) 109 (32) 144 (22)
Distance to clinic one
way, miles
,0.0001
Mean (SD) 56 (38.4) 74 (35.7) 46 (36.0)
Calendar year 0.0005
Mean (SD) 2003 (4.8) 2002 (4.7) 2003 (4.8)
*All characteristics measured at UNC HIV care entry.
†Sixty percent of other race/ethnicity were Hispanic.
IDU, injection drug use; MSM, men who have sex with men.
TABLE 2. CD4 Cell Count Differences (cells/mm3) at HIV Care
Initiation, UCHCC 1996–2012
Characteristic*
Mean CD4 Cell Count Difference (95% CI)
Unadjusted Adjusted†
Residence
Rural 248 (286 to 210) 237 (273 to 22)
Urban 0 0
Sex
Male 290 (2129 to 251) 274 (2118 to 231)
Female 0 0
Age, yrs
$40 284 (2121 to 247) 256 (291 to 221)
18–39 0 0
Race‡
Black 29 (252 to 34) 246 (285 to 27)
Other 250 (2108 to 7) 264 (2119 to 29)
White 0 0
MSM
No 217 (254 to 20) 250 (293 to 28)
Yes 0 0
IDU




$4.5 2251 (2284 to2218) 2240 (2273 to2207)
,4.5 0 0
HCV
Yes 237 (288 to 13) 23 (258 to 53)
No 0 0
Insurance
Public 10 (236 to 55) 15 (228 to 58)
Private 251 (294 to 8) 229 (270 to 12)
None 0 0
Distance to clinic one way,
miles
,40 218 (256 to 21) 227 (264 to 10)
40–59 237 (293 to 18) 217 (264 to 30)
60+ 0 0
Calendar year
1996–2003 262 (2106 to 218) 267 (2108 to 222)
2004–2007 225 (281 to 31) 27 (256 to 42)
2008–2012 0 0
*All characteristics measured at the HIV care initiation.
†Adjusted analyses using multiple linear regression including all characteristics in
the table. Variable parameterization for continuous variables was based on stratified
analyses and model fit.
‡Sixty percent of other race/ethnicity were Hispanic.
IQR, interquartile range.
(Table 1). Rural patients were less likely to have private 
health insurance but more likely to have public insurance than 
urban patients (P = 0.002). Rural patients were more likely to 
reside at longer distances from the clinic with a mean one-
way driving distance of 74 miles (SD, 36) versus 46 miles 
(SD, 36) for urban patients (P , 0.0001). In addition, rural 
patients were more likely to be coinfected with HCV than 
urban patients (20 versus 13%, P = 0.006).
Rural patients had lower CD4 cell counts at HIV care 
initiation compared with urban patients (mean 320 cells/mm3; 
SD 279; versus 368 cells/mm3; SD 295, respectively, P = 
0.01). Overall, 42% of rural versus 34% of urban patients 
initiated care with a CD4 cell count ,200 cells/mm3 (P = 
0.008); and 60% of rural versus 53% of urban patients 
initiated care with a CD4 cell count ,350 cells/mm3 
(P = 0.009).
The unadjusted mean CD4 cell count difference 
comparing rural with urban patients of 248 cells/mm3 
[95% confidence interval (CI): 286 to 210] persisted 
after adjustment for demographic and clinical characteristics 
(237 cells/mm3; 95% CI: 273 to 22) (Table 2). Additional 
factors associated with entering HIV care at more advanced
in earlier calendar years (1996–2003) in comparison with 
later years (2008–2012); however, there seemed to be no 
difference in later years (2004–2007 versus 2008–2012).
Rural patients were more likely to initiate care with 
a CD4 cell count ,350 cells/mm3 when compared with urban 
patients [relative risk (RR) = 1.17, 95% CI: 1.04 to 1.30), and 
this effect persisted in multivariable analyses (RR = 1.12, 
95% CI: 1.02 to 1.23). In unadjusted analyses, rural patients 
were also more likely to initiate HIV care with a CD4 cell 
count ,200 cells/mm3 compared with urban patients (RR = 
1.25, 95% CI: 1.06 to 1.47), although this effect was 
attenuated after adjusting for other covariates in multivariable 
analyses (Adjusted RR = 1.13, 95% CI: 0.98 to 1.30).
Our main study findings were also comparable when 
restricting the study cohort to HIV care initiation between 
2001 and 2012; in these analyses, the unadjusted and adjusted 
rural–urban mean CD4 cell count difference was 287 cells/
mm3 (95% CI: 2136 to 238) and 276 cells/mm3 (95% CI: 
2124 to 227), respectively. A secondary analysis using 
quantile regression gave comparable unadjusted and adjusted 
estimates to linear regression, indicating differences across the 
CD4 distribution, although with less precision (Supplemental 
Digital Content Figure 1, http://links.lww.com/QAI/B54). 
Furthermore, our main study findings were also robust in 
sensitivity analyses where we included patients we could not 
geocode, using multiple imputation methods. In these analy-
ses, the unadjusted mean CD4 cell count difference comparing 
rural with urban patients was 244 cells/mm3 (95% CI: 281 to 
28), and the adjusted result was 246 cells/mm3 (95% CI: 
285 to 27).
DISCUSSION
In this large HIV clinical cohort in the Southeastern 
United States, over one-third of patients lived in areas 
classified as rural, and over one-half traveled over 50 miles 
one way to receive HIV care. Consistently, we observed that 
rural residence was associated with initiating HIV care at 
lower CD4 cell counts, even after accounting for other 
demographic and clinical characteristics. Although few 
studies have examined the association between rural resi-
dence and CD4 cell count at care entry, the lower CD4 cell 
count at care entry among rural patients compared with urban 
patients is consistent with observations from 2 studies of 
HIV-infected U.S. veterans.16,25
Others have observed no difference in the CD4 cell 
count at the time of HIV diagnosis comparing patients from 
rural and urban areas,26–28 suggesting that rural residence 
may not affect the timing of HIV diagnosis but may rather 
affect the time from HIV diagnosis to care initiation. Reasons 
for late care initiation among rural residents may be 
multifaceted. HIV-infected persons living outside urban 
centers may have less access to HIV experts and facilities, 
greater costs, and time incurred when traveling for care, face 
greater stigma, have more concerns about privacy and 
anonymity, perceive they are at lower risk of HIV infection, 
and have fewer or no ancillary care services.15,19 A few 
previous studies among U.S. HIV-infected populations have
observed that rural residents face increased barriers to care 
compared with urban residents.18,19
In general, our patients had substantial travel distances 
to care, and rural patients in our study had longer travel 
distances than urban patients. Transportation and/or distance 
barriers to care have been reported by HIV-infected popula-
tions,15,29,30 and greater travel distance has been associated 
with delayed care entry and/or poorer care engagement for 
several health conditions.31–34 In this study, we did not 
observe a strong effect of distance to the clinic on CD4 cell 
count at HIV care initiation, but our study was not designed to 
specifically examine distance to care.
We observed that men in comparison with women, 
older patients, and racial/ethnic minorities initiated HIV 
care at lower CD4 cell counts. These findings have been 
noted by others.11,13,35 For example, in the North American 
AIDS Cohort Collaboration on Research and Design 
(NA-ACCORD) men versus women initiated HIV care at 
a mean CD4 cell count of 300 versus 349 cells/mm3 in 1997 
and 353 versus 395 cells/mm3 in 2007.11 In the 
NA-ACCORD, participants of white race initiated HIV care 
with a mean CD4 cell count of 328 cells/mm3 versus 305, 
293, or 281 cells/mm3 for participants of black, Latino, or 
other race/ethnicity, respectively, in 1997, whereas in 2007, 
whites initiated care with a mean CD4 cell count of 382 
versus 328 cells/mm3 for blacks.11 Consistent with our 
findings, the NA-ACCORD also showed older patients 
entered care with lower median CD4 cell counts than younger 
patients between 1997 and 2007.35
In our cohort, less than a quarter of patients presented to 
HIV care with a CD4 cell count .500 cells/mm3. This 
finding is concerning, as the International Network for 
Strategic Initiatives in Global HIV Trials (INSIGHT) START 
study group recently reported a benefit to beginning ART at 
a CD4 cell count over 500 cells/mm3 compared with 
beginning ART at 350 cells/mm3 or less.36 Reassuringly, in 
more recent calendar years, we observed an increase in CD4 
cell counts at care entry, and mitigation of the rural–urban 
difference. These results are in line with other North Ameri-
can studies. For example, in a large cohort collaboration of 
the International epidemiologic Databases to Evaluate AIDS 
(IeDEA), the NA-ACCORD observed an increase in median 
CD4 cell count in more recent years, increasing from 256 to 
317 cells/mm3 between 1997 and 2007.11 The HIV Research 
Network, a consortium of 18 US clinics, also observed an 
increase in median CD4 cell count at HIV care initiation, 
rising from 285 to 317 cells/mm3 over the years 2003–2007 
and 2008–2011.37
Notwithstanding increases in CD4 cell count at HIV 
care initiation among both rural and urban residents in more 
recent calendar years, substantial delays in HIV testing and/or 
initial HIV care linkage remained in our cohort even in most 
recent years, consistent with national estimates.38,39 There-
fore, ongoing design, evaluation, and implementation of 
innovative approaches to HIV testing and care linkage is 
needed, such as promising projects detecting HIV-infected 
individuals based on geotargeted community-based interven-
tions reaching marginalized populations,40 new diagnostic 
strategies to detect early HIV infections,41 and
rurality that affect patient care access. Interventions that may
increase earlier care entry such as counseling, video-
conferencing, basic services provision, transportation assis-
tance, or mobile health units in rural areas warrant
further investigation.
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